Anesthetic strategy tailored to avoid triggers during C-section for a woman with SM
A recent case report describes the specially tailored anesthetic protocol for a C-section in a woman with systemic mastocytosis (SM).
A recent case report describes the specially tailored anesthetic protocol for a C-section in a woman with systemic mastocytosis (SM).
Aggressive systemic mastocytosis (SM) can present with nonspecific symptoms like fever, which can complicate diagnosis
A new cumulative analysis from the PIONEER trial provides encouraging long-term data on avapritinib for indolent SM.
A case report was recently published describing a man with systemic mastocytosis and a previously unknown KIT mutation.
Systemic mastocytosis with an associated hematologic neoplasm (SM-AHN) appears to have a higher mutational burden than isolated SM.
A rare presentation of systemic mastocytosis (SM) alongside postural orthostatic tachycardia syndrome (POTS) was recently reported.
Well-differentiated systemic mastocytosis (WDSM), a rare SM variant, was recently associated with previously unknown genetic mutations.
SM is a risk factor for the development of respiratory symptoms, regardless of whether it presents as indolent SM or advanced SM.
A new expanded access program (EAP) has been launched for patients with SM, allowing eligible patients to receive bezuclastinib.
A Phase 2 clinical study called Apex is currently evaluating the safety and efficacy of bezuclastinib in patients with advanced SM.